Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus

Status Completed

Clinical Trial Summary

Systemic lupus erythematosus is a chronic and multisystemic autoimmune disorder which predominantly affecting women. The most common cause of death in lupus patients affected by disease for more than 5 years is cardiovascular disease due to presence of some factors as oxidative stress, pro-inflammatory cytokines , dyslipidemia, diabetes, and hypertension.

Clinical Trial Description

laser acupuncture (active or sham) for one month (3 days/week ) on acupoint number 14 of GV meridian, acupoint number 4 and 11 of large intestine, acupoint number 34 of gall bladder meridian, acupoint number 3 of liver meridian, acupoint number 4, 12, and 9 of conception vessel meridian, acupoint number 40, 36, and 25 of stomach meridian, acupoint number 6 of spleen meridian, and acupoint number 5 of triple energizer meridian (laser will be applied for 1 min on every acupiont) in lupus females ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04970199
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	N/A
Start date	July 12, 2021
Completion date	November 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04024306` - Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
Active, not recruiting	`NCT04018222` - Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Completed	`NCT04527172` - Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
Completed	`NCT05458531` - Monitoring of Inflammatory Conditions
Completed	`NCT03426384` - FLARE Lupus Research Study Systemic Lupus Erythematosus	N/A
Recruiting	`NCT05984316` - Systemic Lupus Erythematosus	N/A
Completed	`NCT03171194` - Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus	Phase 1
Recruiting	`NCT06383104` - Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus.	N/A
Not yet recruiting	`NCT05314881` - NCF Gene & TNFSF4 in SLE Patients	N/A
No longer available	`NCT04907175` - Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)